ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Development of a Novel Transdiagnostic Intervention for Anhedonia - R61 Phase

ClinicalTrials.gov ID: NCT02874534

Public ClinicalTrials.gov record NCT02874534. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 13, 2026, 9:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02874534
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
University of North Carolina, Chapel Hill
Other
Enrollment
57 participants

Conditions and interventions

Conditions

Interventions

  • Behavioral Activation Behavioral
  • Mindfulness Treatment Behavioral

Behavioral

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 21, 2017
Primary completion
Jul 30, 2019
Completion
Jul 30, 2019
Last update posted
Apr 23, 2020

2017 – 2019

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
UNC Chapel Hill Chapel Hill North Carolina 27599

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02874534, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2020 · Synced May 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02874534 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →